RE:JD from Promoter to HaterIt won't be me leading it, doc. The revolt is against a deal that values Bioasis at $5 million or so. Even the Midatech shareholders are revolting.
All in, the combined shareholders of both companies will own only 24% of Biodexa. The rest of the company is owned by Ladenburg Thalmann, Lind and the LT placees.
There is no real value in the deal for the Cresence EGF programs. The Cresence people end up with 0.6% of Biodexa. And yet nobody is mentioning xB3. Why are the players, especially Dr. Deborah Rathjen, not promoting xB3 and its potential of billions of annual revenue? Why are they silent about xB3 while the share prices of both companies have collapsed?
Biodexa has been set up to fail. xB3 has been excluded from current consideration at the expense of share price. Biodexa doesn't get enough money to survive without major financings. xB3 will likely be sold to keep the Biodexa lights on, but not for long. Biodexa, with a billion shares, will likely be rolled back and end up on OTC Markets. If Biodexa survives, the rollback and subsequent financings could wipe out Bioasis shareholder ownership of Biodexa. The private owners of xB3, if they get it, will go on to make billions, if xB3 works as hoped.
That's not hate on my part. That's what the deal allows to happen. I have reported for over a year that xB3, a potential monumentally valuable asset, has been downplayed by Bioasis, either because it is failing or because it's not in the interests of the CEO to expand and promote its value.
Dr. Deborah Rathjen has failed to both expand and promote the value of xB3. All mention of xB3-001, xB3-004 and progranulin have disappeared. Why? Is it incompetence or by intent?
It doesn't matter. Dr. Deborah Rathjen should resign or be voted out. The deal should be cancelled unless it would force a default on debt and the lenders acquire xB3 as a result. If the deal goes through, Dr. Deborah Rathjen, LT and the others will likely get xB3 and take it private anyway. Iit may be too late for Bioasis shareholders to save their investments.
Bioasis shareholders have a very narrow window to retain future value of xB3.
I am not saying for certain that Biodexa will sell xB3 or that it's a setup to do that. I am saying that the way this is going down, it looks like a serup to do just that. And the drops in both companies' share price tell me that Midatech and Bioasis shareholders and the market certainly do not like this deal.
The Midatech shareholders are not listening to Davenport. The Midatech market is falling all on its own. And if Stockhouse forums are a gong show with zero influence, then why did Rathjen want me off of it? Did I cause the drop in Bioasis share price or did Dr. Deborah Rathjen and the deal do that?
She wanted me off of here because she didn't want any light shone on her activities or lack of activities.
I've been around OTC Markets and Pink Sheets for almost 25 years. I've seen these types of complex deals. I know people who have gone to prison for working their magic deals. I don't know what this deal is but it looks to me to be a very clumsy play to allow the cheap spinoff of xB3 from Biodexa. Who would get it? And of course that great expert on xB3 and receptor mediated transcytosis, Dr. Deborah Rathjen will tag along wherever xB3 goes. That move is included in this deal.
Why have the players, including Dr. Deborah Rathjen, been failing to promote xB3 and the Bioasis development programs for the last year and on the behalf of shareholders in this deal?
And why is Biodexa going to end up so weak and with a billion shares outstanding. Why is Bioasis going for less than half its market cap of a week ago?
This deal defines the value of Bioasis as 7¢ and the market is taking the word of the deal players, including Rathjen, on that.
No spin by the players can explain this clumsy and seemingly obvious attempt to achieve goals that appear to be so inconsistent with shareholder interests.
That's my opinion and I've put it on the record. You don't need me to do what you have to do to keep the value of xB3 under your ownership.
jd